Stay updated on Selpercatinib in RET+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET+ NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Location name updated from Napoli, Campania, Italy, 80131 to Naples, Campania, Italy, 80131; page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T17:04:14.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T13:09:32.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    In Turkey, the study site list changed by removing Sarıyer and adding Yellowplace, both with postal code 34457.
    Difference
    0.0%
    Check dated 2026-02-28T06:32:35.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Minor site revision updated from v3.4.1 to v3.4.2; no study content, eligibility criteria, or user-facing actions were changed.
    Difference
    0.0%
    Check dated 2026-02-14T04:56:31.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-06T23:27:08.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    UI and metadata updates include the glossary toggle options (Show glossary, Hide glossary) and a new revision tag (Revision: v3.4.0). The page also updates timestamp-related labels (Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data) and removes older labels (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4).
    Difference
    0.1%
    Check dated 2026-01-23T15:39:12.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET+ NSCLC Clinical Trial page.